Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 05 Mar 2026 for NOVAVAX INC. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Mark J. Casey: trading record in brief
Mark J. Casey (senior executive) discloses dealings in 2 companies, chiefly Novavax Inc and Mallinckrodt plc. In total, 6 filings cover trades dated from 16 June 2022 to 3 March 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 5 March 2026 with an option exercise in Novavax Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark J. Casey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
37,500 shares0Common StockSEC:0001104659-26-023715:0
4,000 shares0Common StockSEC:0001104659-26-023069:0
41,899 shares0Common StockSEC:0001104659-25-121103:0
4,000 shares0Common StockSEC:0001593968-25-000288:0
41,900 shares0Common StockSEC:0001593968-24-001472:0
32,011 shares0Ordinary SharesSEC:0000899243-22-023430:0
6 of 6 declarations
